Aspen Pharmacare

Aspen Pharmacare's reported carbon emissions

Aspen Pharmacare, a Research and development services company headquartered in ZA, has reported its carbon emissions across Scope 1 and Scope 2 for several years. In 2025, the company's Scope 1 emissions were approximately 32,776,000 kg CO2e, with Scope 2 emissions totalling approximately 115,505,000 kg CO2e. This resulted in combined Scope 1 and 2 emissions of about 148,281,000 kg CO2e for that year. Looking back, in 2024, Scope 1 emissions were around 32,468,000 kg CO2e and Scope 2 emissions were approximately 108,515,000 kg CO2e. In 2023, Scope 1 emissions were recorded at approximately 37,424,000 kg CO2e and Scope 2 at 111,877,000 kg CO2e. Prior to this, in 2022, Scope 1 emissions were about 40,082,000 kg CO2e, and Scope 2 emissions were approximately 111,181,000 kg CO2e. In 2021, Scope 1 emissions were approximately 44,544,000 kg CO2e, and Scope 2 emissions totalled around 143,126,000 kg CO2e. Aspen Pharmacare has set ambitious climate targets. The company aims to reduce its global carbon dioxide emissions by 45% by 2030, using 2010 as the baseline year. Furthermore, Aspen Pharmacare is committed to achieving net-zero emissions around mid-century. To support these overarching goals, specific targets include a 50% reduction in absolute combined Scope 1 and Scope 2 carbon emissions by 2030, based on a 2020 baseline. The company also previously aimed to reduce Scope 1 and Scope 2 emissions to near zero by the middle of this decade. Historically, there was a reported reduction in Scope 1 emissions by approximately 64% and Scope 2 emissions by around 44% between 2012 and 2013. Aspen Pharmacare's emissions data is not currently cascaded from a parent organisation. The company has indicated that Scope 3 emissions data is missing for several categories, including purchased goods and services, business travel, and employee commute.